Leukopenia
9
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
Luspatercept for Clonal Cytopenias of Uncertain Significance
Male Infertility Related With Post Infection Inflammatory Syndrome
Hematological Disorders in EHPVO Patients
A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC
Natural History Study for BEN
HIV Indicator Diseases in Hospital and Primary Care
To Investigate the Absorption, Metabolism, Excretion, Absolute Bioavailability, and Immunogenicity of GX-I7 in Healthy Volunteers
Safety and Efficacy Study of Posaconazole vs. Fluconazole for Prevention of Invasive Fungal Infection (P05387 AM1)(COMPLETED)